A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL to EVALUATE the EFFICACY and SAFETY of AVATROMBOPAG for the TREATMENT of CHILDREN with CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)

Authors
Category Primary study
Conference29th Congress of the European Hematology Association, EHA 2024
Year 2024
This article has no abstract
Epistemonikos ID: 51d39c9ac8f9b12453cd1ad1e5aa0c2cf7dd00f9
First added on: Mar 07, 2026